期刊论文详细信息
Implementation Science
Partnership for fragility bone fracture care provision and prevention program (P4Bones): study protocol for a secondary fracture prevention pragmatic controlled trial
Bernard Burnand4  Diane Theriault1,11  Alvine Fansi1  Sonia Jean7  Sophie Laforest2  Johanne Filiatrault1,13  Marie Rochette3  Earl Bogoch1,12  Suzanne Gosselin9  Pierre Dagenais1  Marie-Claude Beaulieu5  François Cabana8  Gilles Boire8  Hélène Corriveau6  Isabelle Gaboury1,10 
[1] Institut national d’excellence en santé et en services sociaux, Montreal, QC, Canada;Institut de recherche en santé publique de l’Université de Montréal (IRSPUM), Montreal, QC, Canada;Ministère de la Santé et des Services sociaux du Québec, Québec, QC, Canada;University of Lausanne, Lausanne, Switzerland;Department of Family Medicine and Emergency Medicine, University of Sherbrooke, Sherbrooke, QC, Canada;Centre de recherche sur le vieillissement, Sherbrooke, QC, Canada;Institut national de santé publique du Quebec, Québec, QC, Canada;Department of Medicine, University of Sherbrooke, Sherbrooke, QC, Canada;Health and Social Services Center- University Institute of Geriatric of Sherbrooke, Sherbrooke, QC, Canada;Centre de recherche clinique Étienne-Le Bel, Sherbrooke, QC, Canada;Osteoporosis Canada, Toronto, ON, Canada;St Michael’s Hospital, Department of Surgery, University of Toronto, Toronto, ON, Canada;Centre de recherche de l’Institut universitaire de gériatrie de Montreal, Montreal, QC, Canada
关键词: Evaluation;    Controlled trial;    Canada;    Interorganizational collaboration;    Integrated program;    Fall prevention;    Osteoporosis;    Fragility fracture;   
Others  :  813821
DOI  :  10.1186/1748-5908-8-10
 received in 2012-12-10, accepted in 2013-01-16,  发布年份 2013
PDF
【 摘 要 】

Background

Fractures associated with bone fragility in older adults signal the potential for secondary fracture. Fragility fractures often precipitate further decline in health and loss of mobility, with high associated costs for patients, families, society and the healthcare system. Promptly initiating a coordinated, comprehensive pharmacological bone health and falls prevention program post-fracture may improve osteoporosis treatment compliance; and reduce rates of falls and secondary fractures, and associated morbidity, mortality and costs.

Methods/design

This pragmatic, controlled trial at 11 hospital sites in eight regions in Quebec, Canada, will recruit community-dwelling patients over age 50 who have sustained a fragility fracture to an intervention coordinated program or to standard care, according to the site. Site study coordinators will identify and recruit 1,596 participants for each study arm. Coordinators at intervention sites will facilitate continuity of care for bone health, and arrange fall prevention programs including physical exercise. The intervention teams include medical bone specialists, primary care physicians, pharmacists, nurses, rehabilitation clinicians, and community program organizers.

The primary outcome of this study is the incidence of secondary fragility fractures within an 18-month follow-up period. Secondary outcomes include initiation and compliance with bone health medication; time to first fall and number of clinically significant falls; fall-related hospitalization and mortality; physical activity; quality of life; fragility fracture-related costs; admission to a long term care facility; participants’ perceptions of care integration, expectations and satisfaction with the program; and participants’ compliance with the fall prevention program. Finally, professionals at intervention sites will participate in focus groups to identify barriers and facilitating factors for the integrated fragility fracture prevention program.

This integrated program will facilitate knowledge translation and dissemination via the following: involvement of various collaborators during the development and set-up of the integrated program; distribution of pamphlets about osteoporosis and fall prevention strategies to primary care physicians in the intervention group and patients in the control group; participation in evaluation activities; and eventual dissemination of study results.

Study/trial registration

Clinical Trial.Gov NCT01745068

Study ID number

CIHR grant # 267395

【 授权许可】

   
2013 Gaboury et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140710013101267.pdf 280KB PDF download
【 参考文献 】
  • [1]Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A: The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 2001, 12(5):417-427.
  • [2]van Staa TP, Dennison EM, Leufkens HG, Cooper C: Epidemiology of fractures in England and Wales. Bone 2001, 29(6):517-522.
  • [3]International Osteoporosis Foundation: Osteoporosis: Facts and statistics. http://www.iofbonehealth.org/facts-and-statistics webcite
  • [4]Cummings SR, Melton LJ: Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359(9319):1761-1767.
  • [5]Leslie WD, O’Donnell S, Lagace C, Walsh P, Bancej C, Jean S, Siminoski K, Kaiser S, Kendler DL, Jaglal S, Osteoporosis Surveillance Expert Working Group: Population-based Canadian hip fracture rates with international comparisons. Osteoporos Int 2010, 21(8):1317-1322.
  • [6]Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR: Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009, 301(5):513-521.
  • [7]Scott V, Wagar L, Elliott S: Falls & Related Injuries among Older Canadians: Fall-related hospitalization & intervention initiatives. Victoria; 2010.
  • [8]SMARTRISK: The economic burden of injury in Canada. Toronto; 2009.
  • [9]Osteoporosis Canada: Osteoporosis at-a-glance. http://www.osteoporosis.ca/index.php/ci_id/5526/la_id/1.htm webcite
  • [10]Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA: Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 1994, 4(5):277-282.
  • [11]Meisinger C, Wildner M, Stieber J, Heier M, Sangha O, Doring A: Epidemiology of limb fractures. Orthopäde 2002, 31(1):92-99.
  • [12]Johnell O, Kanis J: Epidemiology of osteoporotic fractures. Osteoporos Int 2005, 16(Suppl 2):S3-S7.
  • [13]Anonymous: NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7–29, 2000: highlights of the conference. South Med J 2001, 94(6):569-573.
  • [14]Wustrack R, Seeman E, Bucci-Rechtweg C, Burch S, Palermo L, Black DM: Predictors of new and severe vertebral fractures: results from the HORIZON Pivotal Fracture Trial. Osteoporos Int 2012, 23(1):53-58.
  • [15]Bliuc D, Ong CR, Eisman JA, Center JR: Barriers to effective management of osteoporosis in moderate and minimal trauma fractures: a prospective study. Osteoporosis Int 2005, 16(8):977-982.
  • [16]Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A: A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004, 35(2):375-382.
  • [17]Robbins J, Aragaki AK, Kooperberg C, Watts N, Wactawski-Wende J, Jackson RD, LeBoff MS, Lewis CE, Chen Z, Stefanick ML, Cauley J: Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 2007, 298(20):2389-2398.
  • [18]Netelenbos JC, Lems WF, Geusens PP, Verhaar HJ, Boermans AJ, Boomsma MM, Mulder PG, Papapoulos SE: Spine radiographs to improve the identification of women at high risk for fractures. Osteoporos Int 2009, 20(8):1347-1352.
  • [19]Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E: Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 2001, 12(4):271-278.
  • [20]Braithwaite RS, Col NF, Wong JB: Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 2003, 51(3):364-370.
  • [21]Office of Technology Assessment, US Congress: Hip Fracture Outcomes in People Age 50 and Over—Background Paper. OTA-BP-H-120, Washington, DC; 1994.
  • [22]US Department of Health and Human Services: Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD; 2004.
  • [23]Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D: Risk of mortality following clinical fractures. Osteoporos Int 2000, 11(7):556-561.
  • [24]Oliver D: Development of services for older patients with falls and fractures in England: successes, failures, lessons and controversies. Arch Gerontol Geriatr 2009, 49(Suppl 2):S7-S12.
  • [25]Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE: Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 2004, 15(10):767-778.
  • [26]Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM: Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am 2006, 88(1):25-34.
  • [27]Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A: A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 2008, 90(6):1197-1205.
  • [28]Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE Jr, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E, for the ASBMR Task Force on Secondary Fracture Prevention: Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 2012, 27(10):2039-2046.
  • [29]Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH: WITHDRAWN: Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2009, 2(2):CD000340.
  • [30]Barrack CM, McGirr EE, Fuller JD, Foster NM, Ewald DP: Secondary prevention of osteoporosis post minimal trauma fracture in an Australian regional and rural population. Aust J Rural Health 2009, 17(6):310-315.
  • [31]Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD, Scientific Advisory Council of Osteoporosis Canada: clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010 2010, 182(17):1864-1873.
  • [32]Cabana F, Lambert D, Beaulieu M, Boire G: Priming primary care practitioners to treat osteoporosis in their patients with a fragility fracture. J Rheumatol 2010, 37(6):1313.
  • [33]Boire G, Beaulieu M, Lambert D, Cabana F: The OPTIMUS intervention: primary care practitioners treating osteoporosis in up to 64% of patients with fragility fracture. J Bone Miner Res 2009., 24(Suppl 1)
  • [34]Boire G, Cabana F, Beaulieu M, Lambert D, Robindaine J, Poirier N, Larivee L, et al.: How frequent are primary conditions affecting options for osteoporosis treatment among fracture patients seen by orthopaedic surgeons? Ann Rheum Dis 2008, 67(suppl. 2):298.
  • [35]Boire G, Cabana F, Beaulieu M, Lambert D, Robindaine J, Poirier N, Larivee L: Primary conditions potentially affecting treatment of osteoporosis in fracture patients. J Rheumatol 2008, 37(6):1271-1354.
  • [36]Beaulieu MC, Gosselin S, Gaboury I, Vanasse A, Cabana F, Boire G: Treating osteoporosis after a fragility fracture: the family physician as the Hub. J Bone Joint Surg Br 2012, 94-B:196. no. SUPP XXXVIII
  • [37]Cabana F, Beaulieu M, Lambert D, Côté PY, Vaillancourt M, Beaulieu MC, Roux S, Boire G: Incidence of subsequent fractures according to age and site of initial non- vertebral fractures: the first 3 years of the OPTIMUS initiative. J Bone Miner Res 2011., 36(Suppl. 1)
  • [38]Boire G, Cabana F, Mikhail S, Lambert D: Who is Not treated following the implementation of OPTIMUS, a successful initiative to treat osteoporosis following a fragility fracture. J Bone Miner Res 2011., 26(Suppl 1)
  • [39]Institut national de santé publique du Québec: Personalized Multifactorial Intervention. http://www.inspq.qc.ca/dossiers/imp/documents/pied_pmi.pdf webcite
  • [40]Institut national de santé publique du Québec: Falls prevention among seniors living at home. http://www.inspq.qc.ca/dossiers/imp/documents/pied_stand_up.pdf webcite
  • [41]Minkman MM, Ahaus KT, Huijsman R: A four phase development model for integrated care services in the Netherlands. BMC Health Serv Res 2009, 9:42. BioMed Central Full Text
  • [42]Minkman M, Ahaus K, Fabbricotti I, Nabitz U, Huijsman R: A quality management model for integrated care: results of a Delphi and concept mapping study. Int J Qual Health Care 2009, 21(1464–3677; 1):66-75.
  • [43]Minkman MM, Vermeulen RP, Ahaus KT, Huijsman R: The implementation of integrated care: the empirical validation of the development model for integrated care. BMC Health Serv Res 2011, 11(1):177. BioMed Central Full Text
  • [44]D’Amour D, Goulet L, Labadie JF, Martin-Rodriguez LS, Pineault R: A model and typology of collaboration between professionals in healthcare organizations. BMC Health Serv Res 2008, 8:188. BioMed Central Full Text
  • [45]Beaulieu MD, Denis JL, D’Amour D, Gaudreau J, Haggerty J, Hudon E, Jobin G, Lamothe L, Gilbert F, Guay H, Cyr G, Lebeau R: L’implantation des Groupes de médecine de famille: le défi de la réorganisation de la pratique et de la collaboration interprofessionnelle, Étude de cas dans cinq GMF da la première vague au Québec. Montréal; 2006.
  • [46]D’Amour D, Goulet L, Pineault R, Labadie JR, Remondin M: Comparative study of interorganizational collaboration in four health regions and its effects: the case of perinatal services. R04-07 Montréal; 2004.
  • [47]D’Amour D, Sicotte C, Lévy R: Un modèle de structuration de l’action collective dans les services de santé de première lignes au Québec. Sciences Sociales et Santé 1999, 17(3):67-94.
  • [48]Bratton DJ, Nunn AJ: Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials. Int J Tuberc Lung Dis 2011, 15(4):440-446.
  • [49]Treweek S, Zwarenstein M: Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials 2009, 10:37. BioMed Central Full Text
  • [50]Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003, 290(12):1624-1632.
  • [51]Riddle DL, Johnson RE, Jensen MP, Keefe FJ, Kroenke K, Bair MJ, Ang DC: The pragmatic-explanatory continuum indicator summary (PRECIS) instrument was useful for refining a randomized trial design: experiences from an investigative team. J Clin Epidemiol 2010, 63(11):1271-1275.
  • [52]Roland M, Torgerson DJ: What are pragmatic trials? BMJ 1998, 316(7127):285.
  • [53]Champagne F, Gagnon I, Baldé T: Évaluation de l’implantation du continuum de services en prevention des chutes chez les aînés vivant à domicile. http://www.fecst.gouv.qc.ca/fileadmin/documents/R09-02.pdf webcite
  • [54]Statistics Canada: Calculations by HRSDC based on Statistics Canada. Regular medical doctor, by age group and sex, household population aged 12 and over, Canada, provinces, territories, health regions (June 2005 boundaries) and peer groups, every 2 years (CANSIM Table 105–0458). Ottawa; 2006.
  • [55]Bessette L, Ste-Marie L, Jean S, Shawn Davison K, Beaulieu M, Baranci M, Bessant J, Brown JP: Recognizing osteoporosis and its consequences in Quebec (ROCQ): Background, rationale, and methods of an anti-fracture patient health-management programme. Contemp Clin Trials 2008, 29(2):194-210.
  • [56]Gouvernement du Québec: Medical clinics. http://www.santemontreal.qc.ca/en/where-to-go/medical-clinics/#c1944 webcite
  • [57]Tashakkori A, Teddlie C: Mixed methodology: combining qualitative and quantitative approaches. Sage, Thousand Oaks, California; 1998.
  • [58]Creswell JW: Qualitative Inquiry and Research Design: Choosing among five traditions. Sage Publications, Thousand Oaks; 1998.
  • [59]Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley DA, Ioannidis G, Josse RG, Kovacs CS, Towheed T, Kaiser S, Olszynski WP, Prior JC, Jamal S, Kreiger N, Goltzman D, Canadian Multicentre Osteoporosis Study Research Group: Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int 2011, 22(6):1873-1883.
  • [60]Watts NB: The fracture risk assessment tool (FRAX(R)): applications in clinical practice. J Womens Health (Larchmt) 2011, 20(4):525-531.
  • [61]Leslie WD, Lix LM, Manitoba Bone Density Program: Simplified 10-year absolute fracture risk assessment: a comparison of men and women. J Clin Densitom 2010, 13(2):141-146.
  • [62]Scott Leslie R: Calculating Medication Compliance, Adherence, and Persistence in Administrative Pharmacy Claims Databases. http://www.wuss.org/proceedings08/08WUSS%20Proceedings/papers/anl/anl09.pdf webcite
  • [63]Ganz DA, Higashi T, Rubenstein LZ: Monitoring falls in cohort studies of community-dwelling older people: effect of the recall interval. J Am Geriatr Soc 2005, 53(12):2190-2194.
  • [64]Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33(5):337-343.
  • [65]Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34(3):220-233.
  • [66]Jakobsson U, Westergren A, Lindskov S, Hagell P: Construct validity of the SF-12 in three different samples. J Eval Clin Pract 2011, 18(3):560-566.
  • [67]Jakobsson U: Using the 12-item Short Form health survey (SF-12) to measure quality of life among older people. Aging Clin Exp Res 2007, 19(6):457-464.
  • [68]Stewart AL, Mills KM, King AC, Haskell WL, Gillis D, Ritter PL: CHAMPS physical activity questionnaire for older adults: outcomes for interventions. Med Sci Sports Exerc 2001, 33(7):1126-1141.
  • [69]Harada ND, Chiu V, King AC, Stewart AL: An evaluation of three self-report physical activity instruments for older adults. Med Sci Sports Exerc 2001, 33(6):962-970.
  • [70]Strandberg-Larsen M, Krasnik A: Measurement of integrated healthcare delivery: a systematic review of methods and future research directions. Int J Integr Care 2009, 9:e01.
  • [71]Farup PG, Blix I, Forre S, Johnsen G, Lange O, Johannessen R, Petersen H: What causes treatment failure - the patient, primary care, secondary care or inadequate interaction in the health services? BMC Health Serv Res 2011, 11:111. BioMed Central Full Text
  • [72]Berendsen AJ, de Jong GM, Schuling J, Bosveld HE, de Waal MW, Mitchell GK, van der Meer K, Meyboom-de Jong B: Patient's need for choice and information across the interface between primary and secondary care: a survey. Patient Educ Couns 2010, 79(1):100-105.
  • [73]Gignac MA: An evaluation of a psychotherapeutic group intervention for persons having difficulty coping with musculoskeletal disorders. Soc Work Health Care 2000, 32(1):57-75.
  • [74]Harrington JT, Ste-Marie LG, Brandi ML, Civitelli R, Fardellone P, Grauer A, Barton I, Boonen S: Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int 2004, 74(2):129-135.
  • [75]Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P: Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 2008, 1(1):CD004523.
  • [76]Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P: Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 2008, 1(1):CD001155.
  • [77]Langsetmo LA, Morin S, Richards JB, Davison KS, Olszynski WP, Prior JC, Josse R, Goltzman D, CaMos Research Group: Effectiveness of antiresorptives for the prevention of nonvertebral low-trauma fractures in a population-based cohort of women. Osteoporos Int 2009, 20(2):283-290.
  • [78]Guest G, Bunce A, Johnson L: How many interviews Are enough? an experiment with data saturation and variability. Field methods 2006, 18(1):59-82.
  • [79]Morse JM: Determining sample size. Qual Health Res 2000, 10(1):3-5.
  • [80]Stewart DW, Shamdasani PN, Rook DW: Focus groups: theory and practice. 2nd edition. SAGE Publications, Thousand Oaks, California; 2007.
  • [81]Fern EF: The Use of focus groups for idea generation: the effects of group size, acquaintanceship, and moderator on response quantity and quality. J Mark Res 1982, 19(1):1-13.
  • [82]Claxton K: The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999, 18(3):341-364.
  • [83]Miles MB, Huberman AM: Qualitative data analysis: an expanded sourcebook. 2nd edition. Sage, Thousand Oaks, California; 1994.
  • [84]Thorne S, Kirkham SR, MacDonald-Emes J: Interpretive description: a noncategorical qualitative alternative for developing nursing knowledge. Res Nurs Health 1997, 20(2):169-177.
  • [85]Hsieh HF, Shannon SE: Three approaches to qualitative content analysis. Qual Health Res 2005, 15(1049–7323; 9):1277-1288.
  • [86]Sudsawad P: A conceptual framework to increase usability of outcome research for evidence-based practice. Am J Occup Ther 2005, 59(3):351-355.
  • [87]Holey EA, Feeley JL, Dixon J, Whittaker VJ: An exploration of the use of simple statistics to measure consensus and stability in Delphi studies. BMC Med Res Methodol 2007, 7(1471–2288):52.
  • [88]de Villiers MR, de Villiers PJ, Kent AP: The Delphi technique in health sciences education research. Med Teach 2005, 27(0142–159; 7):639-643.
  • [89]Hasson F, Keeney S, McKenna H: Research guidelines for the Delphi survey technique. J Adv Nurs 2000, 32(0309–2402; 4):1008-1015.
  • [90]Garasen H, Johnsen R: The quality of communication about older patients between hospital physicians and general practitioners: a panel study assessment. BMC Health Serv Res 2007, 7:133. BioMed Central Full Text
  • [91]Berendsen AJ, de Jong GM, Meyboom-de Jong B, Dekker JH, Schuling J: Transition of care: experiences and preferences of patients across the primary/secondary interface - a qualitative study. BMC Health Serv Res 2009, 9:62. BioMed Central Full Text
  • [92]Jaglal SB, Hawker G, Bansod V, Salbach NM, Zwarenstein M, Carroll J, Brooks D, Cameron C, Bogoch E, Jaakkimainen L, Kreder H: A demonstration project of a multi-component educational intervention to improve integrated post-fracture osteoporosis care in five rural communities in Ontario, Canada. Osteoporos Int 2009, 20(2):265-274.
  • [93]Geusens P, Dinant G: Integrating a gender dimension into osteoporosis and fracture risk research. Gend Med 2007, 4(Suppl B):S147-S161.
  • [94]Gates S, Fisher JD, Cooke MW, Carter YH, Lamb SE: Multifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis. BMJ 2008, 336(7636):130-133.
  • [95]Glasgow RE, Lichtenstein E, Marcus AC: Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health 2003, 93(8):1261-1267.
  • [96]Canadian Institutes for Health Research: More About Knowledge Translation at CIHR. http://www.cihr-irsc.gc.ca/e/39033.html webcite
  文献评价指标  
  下载次数:17次 浏览次数:18次